Detalhe da pesquisa
1.
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review.
Cost Eff Resour Alloc
; 21(1): 11, 2023 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36721219
2.
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.
Eur J Haematol
; 108(6): 469-485, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35158410
3.
Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
Eur Radiol
; 32(5): 3067-3075, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34973103
4.
Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer.
Value Health
; 25(1): 104-115, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35031089
5.
Evaluating the resource implications of different service delivery models for offering additional genomic findings.
Genet Med
; 23(4): 606-613, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33214711
6.
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Value Health
; 24(12): 1737-1745, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34838271
7.
Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening.
Value Health
; 24(2): 206-215, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33518027
8.
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
Health Qual Life Outcomes
; 18(1): 240, 2020 Jul 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32690011
9.
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer.
Value Health
; 20(10): 1411-1419, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29241901
10.
Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models.
BMC Med Res Methodol
; 17(1): 170, 2017 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29246192
11.
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.
Appl Health Econ Health Policy
; 22(1): 107-122, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37608228
12.
Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach.
Front Pharmacol
; 14: 1255021, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37964874
13.
Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.
Front Pharmacol
; 14: 1249998, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38074129
14.
Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer-A Clinical Vignette Study.
Cancers (Basel)
; 15(21)2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37958401
15.
Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer.
Asia Pac J Clin Oncol
; 19(3): 392-402, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36464923
16.
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
Target Oncol
; 17(5): 539-548, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36063280
17.
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.
Cancers (Basel)
; 14(7)2022 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35406555
18.
Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review.
Eur Urol Open Sci
; 27: 77-87, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34337517
19.
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late.
Diagnostics (Basel)
; 11(1)2021 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33440749
20.
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.
Pharmacoeconomics
; 39(8): 953-964, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34089503